H Baharvahdat1, R Blanc2, R Fahed1, S Smajda1, G Ciccio1, J-P Desilles1, H Redjem1, S Escalard1, M Mazighi1, D Chauvet3, T Robert4, P Sasannejad1, M Piotin1. 1. From the Department of Interventional Neuroradiology (H.B., R.B., R.F., S.S., G.C., J.-P.D, H.R., S.E., M.M., P.S., M.P.). 2. From the Department of Interventional Neuroradiology (H.B., R.B., R.F., S.S., G.C., J.-P.D, H.R., S.E., M.M., P.S., M.P.) rblanc@for.paris. 3. Neurosurgical Department (D.C.), Rothschild Foundation, Paris, France. 4. Neurosurgical Department (T.R.), Ente-Ospedaliero-Cantonale Ospedale Civico di Lugano, Lugano, Switzerland.
Abstract
BACKGROUND AND PURPOSE: Surgical resection is usually considered as the first-line curative strategy for low-grade (Spetzler-Martin grade I-II) brain arteriovenous malformations because it has a high cure rate and low complications. The role of endovascular treatment remains to be clarified in this indication, especially after A Randomized Trial of Unruptured Brain Arteriovenous Malformations. Our objective was to assess the safety and efficacy of first-line endovascular treatment in low-grade brain arteriovenous malformation management at our institution. MATERIALS AND METHODS: Patients with low-grade brain arteriovenous malformations treated primarily with embolization in our department between January 2005 and December 2015 were retrieved from our prospectively collected registry. The primary outcome was the brain arteriovenous malformation obliteration rate, and secondary outcomes were disability or death secondary to brain arteriovenous malformation embolization assessed through modification of the modified Rankin Scale. RESULTS: Two hundred twenty-four patients completed endovascular treatment during the study period and represent our study population. Complete exclusion of brain arteriovenous malformations was achieved in 205 patients (92%), including 62.1% of brain arteriovenous malformation exclusions after a single endovascular treatment session. One patient died of a hemorrhagic complication after endovascular treatment, leading to a mortality rate of 0.4%. Twelve patients (5%) kept a permanent neurologic deficit secondary to a complication of the endovascular treatment. An overall good outcome (mRS 0-2) was reported in 179 patients (80%). CONCLUSIONS: Endovascular treatment might be a suitable alternative to surgical resection for complete exclusion of selected low-grade brain arteriovenous malformations.
BACKGROUND AND PURPOSE: Surgical resection is usually considered as the first-line curative strategy for low-grade (Spetzler-Martin grade I-II) brain arteriovenous malformations because it has a high cure rate and low complications. The role of endovascular treatment remains to be clarified in this indication, especially after A Randomized Trial of Unruptured Brain Arteriovenous Malformations. Our objective was to assess the safety and efficacy of first-line endovascular treatment in low-grade brain arteriovenous malformation management at our institution. MATERIALS AND METHODS:Patients with low-grade brain arteriovenous malformations treated primarily with embolization in our department between January 2005 and December 2015 were retrieved from our prospectively collected registry. The primary outcome was the brain arteriovenous malformation obliteration rate, and secondary outcomes were disability or death secondary to brain arteriovenous malformation embolization assessed through modification of the modified Rankin Scale. RESULTS: Two hundred twenty-four patients completed endovascular treatment during the study period and represent our study population. Complete exclusion of brain arteriovenous malformations was achieved in 205 patients (92%), including 62.1% of brain arteriovenous malformation exclusions after a single endovascular treatment session. One patient died of a hemorrhagic complication after endovascular treatment, leading to a mortality rate of 0.4%. Twelve patients (5%) kept a permanent neurologic deficit secondary to a complication of the endovascular treatment. An overall good outcome (mRS 0-2) was reported in 179 patients (80%). CONCLUSIONS: Endovascular treatment might be a suitable alternative to surgical resection for complete exclusion of selected low-grade brain arteriovenous malformations.
Authors: H Baharvahdat; R Blanc; R Termechi; S Pistocchi; B Bartolini; H Redjem; M Piotin Journal: AJNR Am J Neuroradiol Date: 2014-03-27 Impact factor: 3.825
Authors: Bradley A Gross; Edward A M Duckworth; Christopher C Getch; Bernard R Bendok; H Hunt Batjer Journal: Neurosurgery Date: 2008-09 Impact factor: 4.654
Authors: Robert M Starke; Hideyuki Kano; Dale Ding; John Y K Lee; David Mathieu; Jamie Whitesell; John T Pierce; Paul P Huang; Douglas Kondziolka; Chun-Po Yen; Caleb Feliciano; Rafael Rodgriguez-Mercado; Luis Almodovar; Daniel R Pieper; Inga S Grills; Danilo Silva; Mahmoud Abbassy; Symeon Missios; Gene H Barnett; L Dade Lunsford; Jason P Sheehan Journal: J Neurosurg Date: 2016-03-04 Impact factor: 5.115
Authors: Jan P Boström; Ruth Bruckermann; Bogdan Pintea; Azize Boström; Gunnar Surber; Klaus Hamm Journal: World Neurosurg Date: 2016-07-15 Impact factor: 2.104
Authors: J P Mohr; Michael K Parides; Christian Stapf; Ellen Moquete; Claudia S Moy; Jessica R Overbey; Rustam Al-Shahi Salman; Eric Vicaut; William L Young; Emmanuel Houdart; Charlotte Cordonnier; Marco A Stefani; Andreas Hartmann; Rüdiger von Kummer; Alessandra Biondi; Joachim Berkefeld; Catharina J M Klijn; Kirsty Harkness; Richard Libman; Xavier Barreau; Alan J Moskowitz Journal: Lancet Date: 2013-11-20 Impact factor: 79.321
Authors: Daniel D Cummins; Michael T Caton; Vinil Shah; Karl Meisel; Christine Glastonbury; Matthew R Amans Journal: J Neuroimaging Date: 2021-12-15 Impact factor: 2.486
Authors: Brent C Morel; Blake Wittenberg; Jessa E Hoffman; David E Case; Zach Folzenlogen; Christopher Roark; Joshua Seinfeld Journal: J Pers Med Date: 2022-05-30